ArchiMed Mergers and Acquisitions Summary

Private Equity Firm Profile

In the last 3 years, ArchiMed has acquired 7 companies. It has also invested in 2 others.

ArchiMed’s most common sectors for investment arelife science (31%) and medical products (31%) . The Firm’s most common investment types include buyout (lbo, mbo, mbi) (58%) and secondary buyout (20%). In total, ArchiMed has invested in 5 US states and 10 different countries. Its largest (disclosed) acquisition occurred in 2022 when it acquired Natus Medical for $1.1B.

In the last 3 years, ArchiMed has exited 4 companies. The Firm’s most common exit type is trade sale (80%). ArchiMed’s largest (disclosed) exit occurred in 2023 when it sold Polyplus-transfection SA for $2.7B.

Join Mergr to view ArchiMed’s full profile and discover more middle-market private equity firm investors just like it.

M&A Summary

  • M&A Total Activity31
    • M&A Buy Activity26
    • M&A Sell Activity5
  • Total Sectors Invested 8
  • Total Countries Invested 10
  • M&A Buy/Sell Connections 6
  • M&A Advisors 3

ArchiMed

9 Rue des Cuirassiers,
Lyon, 69003
France
+33 4 81 11 35 33
www.archimed-group.eu
contact@archimed-group.eu

ArchiMed is a specialist French private equity firm focused on buyouts of and growth capital investments in European healthcare-oriented companies. The Firm looks to invest €5 to €300 million per transaction and specifically targets companies in the public health, care and wellness, biotech, and medical technology segments of the healthcare industry. ArchiMed was formed in 2014 and is headquartered in Lyon.


Investment Criteria

Sectors of Interest: Consumer Services, Healthcare Services, Life Science, Medical Products, Test/Measurement Equipment

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Recapitalization, Stake Purchase

Geographic Preferences: United Kingdom, Western Europe, Eastern Europe, Nordic

Transaction Criteria Min Max
Target Revenue 5 100
Target EBITDA - -
Investment Size 5 300
Enterprise Value - -
values in millions of EUR

M&A Summary

Buy vs Sell

Year ≤ '19 '20 '21 '22 '23 '24 T
Buy (2.2/yr) # 15 2 7 2 - - 26
vol $92M $1.1B $1.2B
Sell (0.8/yr) # 1 - - 3 1 - 5
vol $2.7B $2.7B
  31

Most Recent M&A

Company Date Value Type
Polyplus-transfection SA 2023-03-31 2.7B EUR Trade Sale
Illkirch, France · www.polyplus-transfection.com
Bomi Italia S.p.A. 2022-08-08 - Trade Sale
Spino d’Adda, Italy · www.bomigroup.com
Natus Medical, Inc. 2022-07-21 1.1B USD Going Private
Middleton, Wisconsin · www.natus.com
Title21 Software, Inc. 2022-07-12 - Growth Capital
Pleasanton, California · www.title21.com
Eurolyser Diagnostica GmbH 2022-05-09 - Trade Sale
Salzburg, Austria · www.eurolyser.com
Fytexia SAS 2022-02-02 - Trade Sale
Vendres, France · www.fytexia.com
Groupe CARSO 2021-12-16 - Secondary Buyout
Vénissieux, France · www.groupecarso.com
Suanfarma S.A. 2021-11-18 - Secondary Buyout
Alcobendas, Spain · www.suanfarma.com
Cardioline S.p.A. 2021-11-17 - Buyout (LBO, MBO, MBI)
Trento, Italy · www.cardioline.it
Cube Biotech GmbH 2021-11-03 - Buyout (LBO, MBO, MBI)
Monheim, Germany · www.cube-biotech.com
View All >>

Portfolio M&A

Company Acquired Add-On/Sale Date #
Direct Healthcare Group 2019-12-09 Handicare AS - Patient Handling Division 2020-04-09 3
Caerphilly, United Kingdom · www.directhealthcaregroup.com Kista, Sweden

M&A by Sector

Sector Current # Value All-time # Value
Medical Products 8 (40%) 1.1B (100%) 8 (31%) 1.1B (92%)
Life Science 7 (35%) - 8 (31%) -
Healthcare Services 1 (5%) - 3 (12%) 79M (7%)
Software 1 (5%) - 2 (8%) 14M (1%)
Consumer Products 1 (5%) - 2 (8%) -
Business Services 1 (5%) - 1 (4%) -
Technology Hardware 1 (5%) - 1 (4%) -
Test/Measurement Equipment - - 1 (4%) -
Total 20 $1.1B 26 $1.2B

Acquisitions By Geo

State/Country Current # Value All-time # Value
France 5 (25%) - 7 (27%) -
United States 4 (20%) 1.1B (100%) 5 (19%) 1.1B (93%)
  Wisconsin 1 (5%) 1.1B (100%) 1 (4%) 1.1B (92%)
  Ohio 1 (5%) - 1 (4%) -
  Florida 1 (5%) - 1 (4%) -
  California 1 (5%) - 1 (4%) -
  Georgia - - 1 (4%) 14M (1%)
Italy 2 (10%) - 4 (15%) 79M (7%)
United Kingdom 3 (15%) - 3 (12%) -
Germany 2 (10%) - 2 (8%) -
Spain 1 (5%) - 1 (4%) -
Belgium 1 (5%) - 1 (4%) -
Netherlands 1 (5%) - 1 (4%) -
Switzerland 1 (5%) - 1 (4%) -
Austria - - 1 (4%) -
Total 20 $1.1B 26 $1.2B

Acquisitions by Deal Type

Type Current # Value All-time # Value
Buyout (LBO, MBO, MBI) 11 (55%) - 15 (58%) 14M (1%)
Secondary Buyout 5 (25%) - 5 (19%) -
Growth Capital 3 (15%) - 4 (15%) -
Going Private 1 (5%) 1.1B (100%) 2 (8%) 1.2B (99%)
Total 20 $1.1B 26 $1.2B

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 3 (60%) 2.7B (100%)
Secondary Sale 1 (20%) -
Trade Sale 1 (20%) -
Total 5 $2.7B

Top M&A Advisors

Financial Deals
Jefferies
1
Legal Deals
Gianni Origoni Grippo & Partners
1
Latham & Watkins
1

Deal Values

buy # Total
> $1B 1 $1.1B
< $100M 2 $92M
TOTAL $1.2B
Largest Natus Medical, Inc.
$1.1B (2022-07-21)
sell # Total
> $1B 1 $2.7B
TOTAL $2.7B
Largest Polyplus-transfection SA
$2.7B (2023-03-31)

M&A Connections

Deals
Acquired from
Investor(s)
19%
5 (19%)
Exited to
Investor(s)
20%
1 (20%)
Strategic(s)
80%
4 (80%)

FAQ

When was ArchiMed founded?

ArchiMed was founded in 2014.

What type of investor is ArchiMed?

ArchiMed is a private equity firm.

Where is ArchiMed headquartered?

ArchiMed is headquartered in Lyon, France.

 Subscribe to unlock this and 199,698
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

We built Mergr to save people the arduous and time-consuming process of tracking when companies are bought, sold, and who currently owns them.

Every day, new opportunities emerge around M&A and we help professionals of all types comb through transactions, investors, and corporate acquirers via an easy-to-use web database that is accessible to anyone.

Try us for 1 week free today!

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.5K Private Equity Firms
  • 191K M&A Transactions
  • 195K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.6K M&A Advisors
    (Investment Banks and Law Firms)
  • 75K M&A Contacts
    (PE and M&A Advisors)

Ready to try?

Join FREE for 1 Week

No obligation. Cancel anytime.